Review Article
Treatment of Cancer Pain by Targeting Cytokines
Table 1
Drugs targeting cytokines that have been tested in pain control.
| | Drug class | Mechanism of action | Cytokines targeted | Indication in cancer pain treatment |
| | Steroids | Inhibit NF-B | Downregulate TNF- and IL-1 | Adjuvants for cancer pain treatment CNS lesions | | NSAIDs | COX-1 and COX-2 inhibition | Downregulate IL-1, TNF-α, and IL-6. | Adjuvants for cancer pain treatment bone pain | | Opioids | Release of endogenous opioid peptides | Possible inhibition of TNF- and IFN- release | Moderate to severe pain | | Statins | Inhibition of HMG-CoA reductase | FGF, EGF, TGF, and PDGF | Not in use | | Anti-TNF agents | Multiple mechanisms of TNF blocking (antibody) | TNF | Not in use | | IFN- blocking agents | Interaction with CB2 receptor | IFN- | Not in use | | IL-6 blocking agents | Antibodies | IL-6 | Not in use | | Targeting chemokines | Antibodies | Chemokines | Not in use | | Endothelin antagonists | receptor antagonists | Endothelin | Not in use |
|
|